Literature DB >> 18988718

Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines.

James H Jackson1, John Sobolski, Russ Krienke, Ken S Wong, Feride Frech-Tamas, Brian Nightengale.   

Abstract

OBJECTIVES: Despite recommendations from the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7), only 36.8% of patients were at target blood pressure (BP) in 2003 and 2004. The objective of this study was to assess improvements in BP control and treatment patterns before and after the publication of JNC 7.
METHODS: This was a retrospective, time series analysis of 27 provider groups and managed care organizations from 1998 through 2006. Patients with hypertension were identified from more than 4000 physicians. Medical charts were collected and clinical data were evaluated using prevailing JNC criteria during the time period before and after JNC 7.
RESULTS: A total of 19,258 patients were identified with hypertension: 15,258 included in the before-JNC 7 cohort and 4,000 in the after-JNC 7 cohort. BP control in the before-JNC 7 cohort was 40.8% compared with 49.3% in the after-JNC 7 cohort (P < .0001). After controlling for demographic and clinical covariates, patients in the before-JNC 7 cohort were 45% less likely to achieve BP control compared with the after-JNC 7 cohort (odds ratio, 0.551; P < .0001).
CONCLUSION: Although findings indicate BP control is improving, a significant need for further improvement remains.

Entities:  

Mesh:

Year:  2008        PMID: 18988718     DOI: 10.3122/jabfm.2008.06.080025

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  13 in total

1.  Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.

Authors:  Marguerite R Irvin; Amy I Lynch; Edmond K Kabagambe; Hemant K Tiwari; Joshua I Barzilay; John H Eckfeldt; Eric Boerwinkle; Barry R Davis; Charles E Ford; Donna K Arnett
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

Review 2.  Antihypertensive therapy and the J-curve: fact or fiction?

Authors:  Monique S Tanna; Sripal Bangalore
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 3.  Moxibustion for hypertension: a systematic review.

Authors:  Jong-In Kim; Jun-Yong Choi; Hyangsook Lee; Myeong Soo Lee; Edzard Ernst
Journal:  BMC Cardiovasc Disord       Date:  2010-07-05       Impact factor: 2.298

4.  Potassium and risk of Type 2 diabetes.

Authors:  Ranee Chatterjee; Hsin-Chieh Yeh; David Edelman; Frederick Brancati
Journal:  Expert Rev Endocrinol Metab       Date:  2011-09

5.  Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal.

Authors:  Manuel P Morgado; Sandra A Rolo; Luísa Pereira; Miguel Castelo-Branco
Journal:  BMC Health Serv Res       Date:  2010-12-30       Impact factor: 2.655

6.  Predictors of uncontrolled hypertension and antihypertensive medication nonadherence.

Authors:  Manuel Morgado; Sandra Rolo; Ana Filipa Macedo; Luísa Pereira; Miguel Castelo-Branco
Journal:  J Cardiovasc Dis Res       Date:  2010-10

Review 7.  A review on prescribing patterns of antihypertensive drugs.

Authors:  Noah Jarari; Narasinga Rao; Jagannadha Rao Peela; Khaled A Ellafi; Srikumar Shakila; Abdul R Said; Nagaraja Kumari Nelapalli; Yupa Min; Kin Darli Tun; Syed Ibrahim Jamallulail; Avinash Kousik Rawal; Ranjani Ramanujam; Ramesh Naidu Yedla; Dhilip Kumar Kandregula; Anuradha Argi; Laxmi Teja Peela
Journal:  Clin Hypertens       Date:  2016-03-27

8.  To what extent do prescribing practices for hypertension in the private sector in Zimbabwe follow the national treatment guidelines? An analysis of insurance medical claims.

Authors:  Victor Basopo; Paschal N Mujasi
Journal:  J Pharm Policy Pract       Date:  2017-12-04

9.  Doctors' Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice.

Authors:  Nafees Ahmad; Amer Hayat Khan; Irfanullah Khan; Amjad Khan; Muhammad Atif
Journal:  Int J Hypertens       Date:  2018-03-12       Impact factor: 2.420

10.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.

Authors:  Rohan Khera; Yuan Lu; Jiapeng Lu; Anshul Saxena; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  BMJ       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.